Publication

Affording autism an early brain development re-definition

Downloadable Content

Persistent URL
Last modified
  • 08/27/2025
Type of Material
Authors
    Ami Klin, Emory UniversityMegan Micheletti, University of Texas AustinCheryl Klaiman, Emory UniversitySarah Shultz, Emory UniversityJohn Constantino, Emory UniversityWarren Jones, Emory University
Language
  • English
Date
  • 2020-10-01
Publisher
  • Cambridge University Press (CUP)
Publication Version
Copyright Statement
  • © The Author(s), 2020. Published by Cambridge University Press
License
Final Published Version (URL)
Title of Journal or Parent Work
Volume
  • 32
Issue
  • 4
Start Page
  • 1175
End Page
  • 1189
Grant/Funding Information
  • This work was supported by grants from the National Institute of Mental Health (P50-MH100029 (AK); R01 MH118285 (WJ); R01 MH121363 (WJ); K01 MH108741 (SS); R01 MH11925 (L Li & SS). Additional support was provided by the Marcus Foundation, the J.B. Whitehead Foundation, the Cox Foundation, and the Georgia Research Alliance.
Abstract
  • The national priority to advance early detection and intervention for children with autism spectrum disorder (ASD) has not reduced the late age of ASD diagnosis in the US over several consecutive CDC surveillance cohorts, with traditionally under-served populations accessing diagnosis later still. In this review, we explore a potential perceptual barrier to this enterprise which views ASD in terms that are contradicted by current science, and which may have its origins in the current definition of the condition and in its historical associations. To address this perceptual barrier, we propose a re-definition of ASD in early brain development terms, with a view to revisit the world of opportunities afforded by current science to optimize children’s outcomes despite the risks that they are born with. This view is presented here to counter outdated notions that potentially devastating disability is determined the moment a child is born, and that these burdens are inevitable, with opportunities for improvement being constrained to only alleviation of symptoms or limited improvements in adaptive skills. The impetus for this piece is the concern that such views of complex neurodevelopmental conditions, such as ASD, can become self-fulfilling science and policy, in ways that are diametrically opposed to what we currently know, and are learning every day, of how genetic risk becomes, or not, instantiated as lifetime disabilities.
Author Notes
  • Ami Klin PhD, Marcus Autism Center, Emory University School of Medicine and Children’s Healthcare of Atlanta, 1920 Briarcliff Rd NE, Atlanta, GA 30329, Tel: 404-785-5762, ami.klin@emory.edu

Tools

Relations

In Collection:

Items